fda glp-1 safety warning september 2025 RA prescription trends: January 2018 – March FDA and Novo Nordisk Warned

Ozempic, INN-semaglutide EPAR product information

Their actions on brain insulin signaling, neuroinflammation, oxidative stress, and mitochondrial function likely contribute to improvements in motor and non-motor symptoms, including cognition, mood, and apathy, while maintaining a neutral effect on dyskinesias

This contrasts with traditional diabetes care, where prescribing is typically embedded in a long-term physician-patient relationship within a defined healthcare system

If youre ready to take the next step in personalizing healthcare to best fit your workforce, lets chat.

She maintained the use of compression garments throughout her therapy, which supported circulation and helped optimize results